Australian Clinical Labs Ltd
ASX:ACL
Australian Clinical Labs Ltd
ASX:ACL
Price:
2.83
AUD
-1.05%
Market Closed
Market Cap:
555.8m
AUD
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA
11.1
Current
11.8
Median
11.7
Industry
Lower
than median
Lower
than industry value
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
EV/EBITDA
=11.1
Enterprise Value
/
746.6m AUD
EBITDA
67.5m AUD
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBITDA
3.6
2-Years Forward
EV/EBITDA
3.4
3-Years Forward
EV/EBITDA
3.3
You don't have any saved screeners yet
